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1CHAPTER I 
 
INTRODUCTION 
Injection-site lesions in beef occur at every level of production.  When an injection is 
administered tissue damage occurs in the muscle.  The severity of this damage is 
dependent upon route of administration, type of pharmaceutical used and cleanliness of 
conditions.  In the past, there was a significant problem with injection-site lesions in the 
top butt.  Through extensive education of cow/calf, stocker, and feedyard producers there 
has been a decrease in lesions found in this location.   Now it is recommended that all 
subcutaneous and intramuscular injections be given anterior to the scapula.   
 The traditional type of administration is a needle and syringe, but in recent years 
there have been new technologies developed using a pneumatic, needle-less injection, 
and a ballistic, air powered delivery system that utilizes bio-bullets for pharmaceutical 
administration.  The notable difference between these three routes of administration is 
that cattle do not have to be restrained in order for the bio-bullet to be utilized. From a 
producer standpoint, there is a considerable amount of labor and animal stress involved 
with gathering cattle for vaccination, especially if the vaccinations must be repeated after 
several weeks.                              
After an injection occurs the integrity of the muscle can be affected up to three 
inches away from the site.  Injection-site lesions do not shrink in size as they grow older, 
but instead grow with the animal.  When the wound from an injection is in the healing 
process there is a deposition of fat and connective tissue where the muscle tissue was 
disrupted.  This deposition increases the shear force taken to sever the muscle up to three 
2inches away from the site of the injection. As a result, the usable portion of muscle is 
directly affected from a lean tissue standpoint and consumer acceptability from a 
tenderness standpoint. It is with the beef purveyors, who lose profit due to trim loss, and  
beef consumers, who do not have a pleasurable eating experience that the beef industry 
loses money and consumer confidence. 
 
3CHAPTER II 
 
REVIEW OF LITERATURE 
 
Occurrence of Injection Site Lesions in Today’s Beef Industry
Vaccines, antimicrobials, and vitamins injected into the muscle have been shown 
to cause injection-site lesions and create tough beef, with the extent of damage depending 
on the calf's age at injection, the volume of the product injected per site, the anatomical site 
of the injection, the route of injection, and the product administered (Van Donkersgoed et 
al., 2000).  Injection-site lesions are caused by several factors including the animal’s 
sensitivity to the vaccine, the vaccination injury itself, the adjuvant used to enhance the 
immune response, and contamination of the needle and hide at the time of vaccination 
(Straw et al., 1986).   
Age of Animal. Pharmaceuticals are commonly administered to cattle at various stages of 
their lives (Taylor and Field, 1999). Clostridial diseases can affect beef cattle of all ages, 
but are a primary concern in cattle between 6 months and 2 years of age.  Because feeder 
cattle are marketed by the time they reach 2 years of age, vaccinating for clostridial 
disease is an important matter for cow-calf producers, stocker cattle operators, and 
feedlot managers (Troxel et al., 2001). Since feedlot managers do not know the injection 
history of the cattle they have on feed, administering another clostridial vaccination is 
very inexpensive insurance (Galyean and Eng, 1998).  It has been reported that between 
93.2 to 99.9% of lesions found at the retail/purveyor level were chronically aged lesions 
that occurred early in life (George et al., 1995a). 
4Tissue damage. Damaged beef muscle tissue resulting from intramuscular injections of 
animal health products represents a “quality control” problem and an economic loss to 
the beef industry (Roeber et al., 2001).  This loss is not taken by the producer or the 
packing plant, but by the retailer and inevitably the consumer.  According to Roeber 
(2002) “injection site lesions are seldom detected at packing plants because damage is 
concealed within the muscles and below the subcutaneous fat.”  This means that the 
injection-site damage will be mainly discovered at the retail establishment where primal 
cuts are fabricated into retail cuts (Roeber, 2002).  As a result, the purveyor or retailer 
will be responsible for removal of the usually affected area and the consumer’s odds of 
getting a tough steak increase.  According to George et al. (1995a) tenderness is affected 
whether the injection site lesion is visible within a steak or not.  In beef rounds, it was 
found that cores sampled as far as 7.6 cm from the center of the injection-site lesion had 
average shear force values of 5.8 kg, thereby being considered tough by retailers and 
purveyors (George et al., 1995b).  According to the National Beef Quality Audit -1995 
30% of  beef packers, purveyors, and retailers indicated that the incidence of injection-
site lesions had declined since the 1991 NBQA (Smith et al., 1995); however, these same 
packers, purveyors and retailers still named injection-site lesions among the top ten 
challenges of fed cattle.   
Roeber et al. (2001) found that between November 1995 and July 2000, the 
incidence of lesions classified as ‘nodular’ (lesion with nodules, the central foci of 
necrosis, surrounded by granulomatous inflammation) and ‘mineralized’ (lesion 
containing 
5mineralized remnants of muscle cells) decreased significantly, but the occurrence of 
‘clear’ lesions (older lesions that contain clear connective tissue) increased significantly.  
During this same time frame, 84% of the lesions were classified as ‘older’ lesions 
(Roeber et al. 2001).  A change in lesion type could be due to a more critical selection of 
vaccine types, lower-dose vaccines, adjuvant changes, and the introduction of new 
products.   
Reductions in lesion incidence in top sirloin butts from U.S. fed steer and heifers 
for the period of November 1995 through July 2000 (11.4% to 2.1%) generated an 
approximate net savings of $2.15 per calf slaughtered.  This equated to an industry-wide 
savings of $7,078,100, based on the projected numbers of cattle to be harvested in 2000 
(USDA, 2000). 
 
Routes of Administration
Needle Injection. Needle injection, the traditional injection administration technique, is 
listed in many studies involving lesions and their impact on tenderness. While the 
abscesses and muscle damage that can develop at injection sites are clearly undesirable, a 
potentially more serious problem for the meat industry is the presence of broken needles 
and needle fragments in carcasses. Breakage of needles typically occurs when needles are 
bent, re-straightened and continued in use for injections (Hoff and Sundberg, 1999).  
Because the detection of needle fragments in muscle and meat is limited, a significant 
number of needle fragments are likely to be found in finished, processed meat products. 
The potential for consumer dissatisfaction is obvious. Lawsuits for several millions of US 
6dollars have been filed by consumers who have encountered needle fragments in 
processed meats (Murphy, 2001).  
 In the mid 1990’s, cattle feeders received and responded to messages regarding 
ways to decrease the incidence of injection site lesions, but the message was not being 
received by producers in other segments of the beef industry who have control of the 
cattle at earlier stages in life.  Additionally, some educational efforts to reduce lesion 
occurrence in the top sirloin butt resulted in producers giving injections in the inside and 
outside round.  Producers also argued, at this point, that injection-site issues were a 
“feedlot problem”.  As a result, a study was conducted by Colorado State University to 
determine if age of the animal was influential in the development of injection site lesions.  
This study indicated that lesions occurred at harvest in both cattle that were 
intermuscularly injected at 2 months and 6 months of age.  This provides irrefutable 
evidence that the location of the injection and the timing (age when given) of injection 
are most important determinants in resulting injection-site lesions (George et al., 1995a).   
Troxel et al. (2001) reported that 28 days after injection, 64.9% of cattle 
developed injection-site lesions after being administered a clostridial vaccination with 
needle and syringe.  The same study reported that 45% of cattle had smaller, but still 
detectable lesions 112 d after injection (Troxel et al., 2001).  Futhermore, it was reported 
that following the often required second injection, the percentages of injection-site 
lesions and injection-site swelling were greater than those occurring after the first 
injection. Troxel et al. (2001) also documented that titers against clostridial diseases are 
enhanced when injection site lesions develop.     
7Some recommendations for avoiding injection-site lesions that have been 
provided to cattle producers and veterinarians include:  (1) administer all clostridial 
bacterins subcutaneously in the neck regions, preferably using the ‘tented’ technique, (2) 
avoid multiple or repeat injections of clostridial bacterins, especially late in the feeding 
period,  (3) avoid intramuscular injections of all products when other routes of 
administration are listed in the label recommendations, (4) use acceptable intramuscular 
and subcutaneous injection locations, (5) encourage the use of subcutaneous routes 
whenever possible, (6) inject no more than 10 mL per injection site, (7) change needles 
every 15 injections (more frequently if cattle are dirty), (8) immediately discard bent 
needles, do not straighten and reuse them, (9) do not use products that damage edible 
tissue at any time during production, (10) choose products that are approved for 
subcutaneous, intravenous or oral administration whenever possible, and (11) choose 
products that have low-volume doses whenever possible (George et al., 1997).   
 The location of the site of injection of clostridial vaccines on beef cattle may be 
important not only because of the seroconversion and damage to the carcass evident at 
slaughter, but also because of the decrease in performance during the early part of the 
finishing program.  Subcutaneous vaccination in the ear produced performance that was 
not different from vaccination anterior to the scapula.  Vaccination in the ear did produce 
a greater proportion of lesions at the base of the ear than prescapular vaccination, but it 
was observed that there was little effect on performance (Chirase et al., 2001).   
Bio-bullet Injection. Most prior investigations have only included needle and syringe 
types of injection.  SolidTech Animal Health Inc., Newcastle, OK, has created a method 
that uses an air powered delivery system and biodegradable projectiles such as freeze 
8dried ceftiofur sodium. Utilization of the bio-bullet technology is increasing because it 
can save producers time and decrease labor because producers do not have to gather 
cattle again for re-vaccination.  Producers are often reluctant to revaccinate due to stress, 
shrink, as well as possible injury and increased labor cost. The bio-bullet biodegradable 
implant is fired with the help of compressed air.  The 1.59 cm long, .64 cm diameter bio-
bullet travels at 274.2 feet per second. The bio-bullet which is fired contains the bacterins 
or active ingredient and the capsule in which the ingredient is placed.  The active 
ingredient is freeze dried and the capsule casing assimilates natural components of the 
animals body (Hansen, 2001).  The bio-bullet pierces the skin and inserts 1 to 3 cm into 
the muscle (Haley, 2000).  When the product penetrates animal tissue, the bacterin 
releases within three hours and the casing liquefies within 24 hours.  The animal’s body 
assimilates the casing ingredients (Hansen, 2001).  
Morgan et al. (2004) reported that cattle receiving bio-bullet treatments more than 
21d before slaughter had no detectable injection site lesions in the biceps femoris muscle.  
Furthermore, only steers treated with the bio-bullet implant at 7 and 14 d before slaughter 
displayed presence of injection-site lesions in the biceps femoris; thus, no detrimental 
effects on beef tenderness would likely be realized with a bio-bullet treatment of 21 d or 
more before slaughter (Morgan et al., 2004).  
 Needle-less Injection. The needle-less route of administration, while infrequently used, 
holds some advantages to the needle and syringe.    This alternative would unequivocally 
remove all risk of needle fragments in pork products if used for delivery of vaccines, 
sera, and antibiotics.  These devices have been observed to have several advantages in 
9human applications, including faster delivery of injected compounds to the circulatory 
system than traditional subcutaneous injections (Henry, 2000).   
 
Product Quality
Wound Healing. Tenderness or shear force is dependent upon many factors, but 
decreasing tenderness issues due to injection-site lesions can be controlled.  Once an 
animal has been administered an injection, a wound will be created and it will take time 
to heal that wound.   As mentioned above, most lesions that were identified came from 
old wounds (George et al., 1995a).   Similar to a fire brand applied to the hide of a calf, as 
the calf grows, the injection-site lesion will also grow.  When a wound heals, there are 
architectural changes that occur in the collagen matrix due to the intricate process of 
remodeling.  In addition to the deposition and maturation of collagen, a rise in tensile 
strength occurs (Harkness, 1968).  The ratio of wound collagen to mucopolysaccharide is 
the best determinant of the gain in tensile strength.  The alterations in the cohesive forces 
between collagen microstructures are directly related to this ratio (Bryant and Weeks, 
1967).  It was also observed that the number of effective network chains, per unit volume 
had a direct impact on load-bearing structure, not the total number of chains (Milch, 
1965).   
Warner-Bratzler Shear Force Values.  It has been observed that when using the bio-bullet 
administration technique, the cooked beef tenderness was negatively affected only when 
administration resulted in the development of injection-site lesions, and this associated 
toughness was only observed in the direct location of the lesion core (Morgan et al., 
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2004).   Morgan et al. (2004) reported that samples isolated from the lesion core location 
of bio-bullet steaks and control samples located 5.08 cm from core locations had similar 
Warner-Bratzler shear force values compared with other treated and control samples. In 
George et al., (1995), cores were taken from the center of the injection lesion sites and 
from sites located 2.54, 5.08, and 7.62 cm away from the lesion center for Warner-
Bratzler Shear Force.  The Warner-Bratzler Shear Force values for lesioned steaks were 
13.87, 10.00, 7.6, and 5.8 kg at the center of the lesion, 2.54 cm, 5.08 cm, and 7.62 cm, 
respectively, which was different from control steak (no lesions present) measurements of 
4.11 kg at 2.54 cm, 4.30 kg at 5.08 cm, and 3.90 kg at 7.62 cm.  According to Savell et 
al., 2006 in the overview of the National Beef Tenderness Study, Warner-Bratzler Shear 
Force Values for all grades of shoulder clod steaks combined to be 2.81kg, and 3.4 kg for 
all grades of eye of round steaks and 3.67 kg for all grades of bottom rounds steaks, 
respectively.      
Collagen Determination.  Light et al. (1985) observed a correlation between toughness 
and collagen content of muscles.  It was reported that in connective-tissue reactions to 
injury in wound healing, or in a fibroproliferative process, there is initially neosynthesis 
of collagens of pericellular type V and basement membrane type IV.  Eventually, 
synthesis and deposition occurs of fine, fibrillar type III collagen, which is followed 
closely by the formation of a matrix composed of interstitial type I collagen resembling 
scar tissue (Sherman et al., 1980).  Type I collagen is reported to have a larger diameter 
than type III collagen that is correlated with decreased muscle tenderness (Gay, 1983).  
To go along with this increase in the concentration of collagen and the increase in 
diameter of collagen fibrils is the loss of solubility of collagen; collagen solubility 
11 
 
decreases progressively with age due to the development of heat-stable covalent 
interchains (Bailey, 1972).   
Morgan et al. (2004) found that increases in total, soluble, and insoluble collagen 
concentrations at the lesion center decreased in concentration as the radius from the 
lesion center increased.   It was also suggested that this result would imply that a 
fibroproliferative process occurred subsequent to intramuscular injection of a 
pharmacological agent, forming a lesion core and resulting in cooked meat toughness.   
George et al. (1995b) reported that core samples taken at a distance of 5.08 cm 
from the center of the lesion required greater shear-force to sever than cores from 
corresponding control steaks, but that the amount of insoluble (heat stable) collagen was 
not significantly different, and was actually numerically lower than in control steak 
samples.  This could be explained as the collagen assay that was employed measures 
hydroxyproline residues, and the percentage of residues differs for type I collagens and 
type III collagens.   Regardless, the significant correlations (r = 0 .67 and 0.50; P < 0.001) 
between Warner-Bratzler shear values and insoluble as well as soluble collagen 
concentrations, respectively, indicate that the increase in these parameters accounts for 
the majority of the differences in shear force values (George et al., 1995b).   
 
Summary
There were few studies that investigated different types of injection 
administration routes in beef chuck and round muscles.  Additionally, the number of 
studies evaluating the decrease in beef tenderness due to type of pharmaceutical 
administered and route of administration was limited.  However, in the studies that were 
12 
 
similar to the study at hand, there were contrasts in the findings regarding tenderness and 
lesion-site injections.  The findings of George et al. (1995b) suggested that tissues as 
much as 5.08 cm from the lesion core were negatively altered in terms of tenderness, 
collagen amount and tissue proportions.  These findings were contradicted by Morgan et 
al. (2004) who reported that only minor tissue alterations were evident in the biceps 
femoris from steers treated with the bio-bullet implant procedure immediately before 
slaughter.  Prior to the start of the project it was hypothesized that there would be visible 
tissue damage in some cases, and that tissue damage would decrease tenderness values in 
steaks from the lesion core and some distance away from the lesion core.
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CHAPTER III 
 
COMPARISON OF THE BIO-BULLET VERSUS TRADITIONAL INJECTION 
TECHNIQUES ON TISSUE DAMAGE AND TENDERNESS IN BEEF SUBPRIMALS 
 
ABSTRACT
The incidence and severity of injection-site lesions has decreased since the start of 
the Beef Quality Assurance program.  This investigation evaluated route of 
administration and its effect on the tenderness, collagen concentration, and histological 
evaluations on beef chucks and rounds. One hundred ninety two yearling steers (initial 
BW = 383 ± 29.4 kg) were sorted from a group of 454 steer calves received from central 
Oklahoma auction markets between January 16 and February 2, 2006.  Based on initial 
BW, steers were blocked into 2 groups of 96 each and randomly allocated within block 
into pens of 6 head each (16 pens per block).  Each pen was randomly assigned an 
injection treatment protocol.  On May 19, 2006 (d 0), steers were administered treatment 
injections of one of the following: standard BioBullet containing 100 mg of Naxcel; a 
traditional needle and syringe dose of Naxcel; a standard Biobullet containing Titanium 
5; a traditional needle and syringe dose of Titanium 5; a needle-less injection of Vista 5; a 
traditional needle and syringe dose of Vira Shield 5; a standard BioBullet containing no 
pharmaceutical product; and a traditional needle and syringe dose of sterile water. 
Additionally, steers were implanted with estradiol and trenbalone acetate (Revalor-S, 
Intervet, Millsboro, DE) and sorted into home pens.  Final individual BW was collected 
the day prior to shipment (d 101 for steers in block 1 and 122 for steers in block 2).   
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The majority of the lesions identified were clear scars (n = 108 out of 121) in the 
chuck and round.  In all steaks evaluated, there were mature fibrous tissue and collagen 
fibers within adipose tissue.  Warner-Bratzler Shear Force values of lesion center cores in 
chucks were found to be significantly different (P = 0.07) than cores from the control 
steaks, and at 2.54 and 5.08 cm away from the lesion core.   Lesion cores from the 
BioBullet * Titanium 5 had a Warner-Bratzler Shear Force value of 7.01 kg, which were 
greater (P < 0.05) than lesion center cores from chucks injected with a BioBullet * H20
(6.27 kg) or a Needle * Naxcel (5.08 kg). There were no significant differences (P > 0.10) 
observed in the total collagenous connective tissue (B) in samples extracted from the 
chuck or round. The comparison between the lesion site and control (no lesion site) 
samples for lipid concentration showed no significant difference (P > 0.10) for route and 
product in the round.   
 It was concluded that the BioBullet did not create a greater incidence of lesions in 
the chuck or round.  Additionally, it was observed that the BioBullet injection did not 
create more tissue damage than intramuscular injections with a needle route of 
administration.  With this in mind, it is still not appropriate to use the BioBullet in the 
round of animals as it does causes similar damage to a needle.  The BioBullet can, 
however,  effectively be used in prescapular applications without additional negative 
effects on tenderness.   
 
INTRODUCTION
The National Cattlemen’s Beef Association has worked for more than 15 years on 
developing the Beef Quality Assurance program to resolve quality challenges such as 
tissue damage and tenderness complications created by injection-site damage in the top 
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sirloin butt and in muscles of the round.  In the late 1990’s George et al. (1997) 
demonstrated that subprimals that contained lesions (visible or non-visible) had higher (P 
< 0.01) shear force values and greater tenderness variation than non-injected control 
subprimals.  As a result of this and similar research, greater influence was placed on 
moving injections to the neck region for all routes of administration of pharmaceutical 
products.   
 More recently, SolidTech Animal Health Inc., Newcastle, OK has devised a 
method for injectable administration that uses an air-powered delivery system and 
biodegradable projectiles containing products such as freeze-dried ceftiofur sodium.  
These bio-bullets penetrate into the animal’s muscle and begin to be absorbed.  Morgan 
et al. (2004) conducted a preliminary study on the impact of these bio-bullets on tissue 
damage and tenderness in beef rounds.  Morgan et al. (2004) documented that visible 
tissue damage was limited in cattle that were treated with bio-bullets 21, 28, and 35 days 
prior to slaughter.   
 While the research conducted by Morgan et al. (2004) indicates that the bio-bullet 
administration method of Naxcel, when used at least 30 days prior to harvest, led to no 
detectable increase in tissue damage or tenderness, no comparisons between the bio-
bullet and traditional administration techniques have been made.  
 The current study was conducted to evaluate lesion occurrence, tenderness, and 
collagen content between different routes of injection administration.  If there was little 
difference between the injection techniques in these areas, the utilization of new injection 
technologies could save producer time and livestock stress. 
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MATERIALS AND METHODS
Cattle. Steers (n = 192) of known treatment history were selected and transported to the 
Willard Sparks Beef Cattle Research Center at Oklahoma State University. One hundred 
ninety two yearling steers (initial BW = 383 ± 29.4 kg) were sorted from a group of 454 
steer calves received from central Oklahoma auction markets in between January 16 and 
February 2, 2006.  Cattle had no previous injections in the neck or round muscles on the 
animal’s right side before the initiation of the trial.  The steers had previously been used 
in receiving and growing experiments at the Willard Sparks Beef Research Center 
(WSBRC).  Steers were considered for inclusion in the study based on no prior 
treatments for bovine respiratory disease, British x continental phenotype, and body 
weight.  Beginning May 17, 2006, steers were individually weighed on two consecutive 
days for allocation.  All steers had been program-fed a 94% concentrate diet for at least 
30d prior to initial weighing.  Based on initial BW, steers were blocked into 2 groups of 
96 head each and randomly allocated within block into 32 pens of 6 head each (16 pens 
per block).  Each pen was randomly assigned an injection treatment protocol.  On May 
19, 2006 (d 0), steers were administered the appropriate treatment injection: standard 
BioBullet containing 100 mg of Naxcel (1 BioBullet administered on right side, 2 
BioBullets administered on left side); a traditional needle and syringe dose of Naxcel (3.5 
mL using a 2.54 cm, 16 gauge needle); a standard Biobullet containing Titanium 5 (1 
BioBullet administered on right side, 2 BioBullets administered on left side); a traditional 
needle and syringe dose of Titanium 5 (2 mL using a 2.54 cm, 16 gauge needle); a 
needle-less injection of Vista 5 (2 mL); a traditional needle and syringe dose of Vira 
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Shield 5 (5 mL subcutaneous, 1.59 cm, 16 gauge needle); a standard BioBullet containing 
no pharmaceutical product (1 BioBullet administered on right side, 2 BioBullets 
administered on left side); and a traditional needle and syringe dose of sterile water (5 
mL, 2.54 cm, 16 gauge needle).  Steers were also implanted with estradiol and trenbalone 
acetate (Revalor-S, Intervet, Millsboro, DE); and sorted into home pens.  Steers were fed 
in 4.6 m x 15.2 m partially covered (by a 4.6 m metal awning) feedlot pens.  Water was 
offered ad libitum in fence-line basins and 0.8 m of bunk space was available per steer.  
An 84% concentrate ration was initially offered at 2% of initial BW and gradually 
increased over 7 days.  For the remainder of the trial, steers were twice daily fed ad 
libitum a 95% concentrate finishing diet.  Orts were weighed at the end of each weigh 
period and when feed became old or wet. 
Steers were weighed on a pen basis on d 56.  Final individual BW was collected the day 
prior to shipment (d 101 for steers in block 2 and d 122 for steers in block 1).  Steers in 
block 1 were also weighed on a pen basis on d 101.  All weights except for individual 
BW were given a pencil shrink of 4% for ADG and G:F calculations.  Carcass adjusted 
final weight was also calculated by dividing individual hot carcass weight by average 
dress for each block (64.47% for block 1 and 64.78% for block 2).  One steer died of 
bloat during the trial.     
 
Treatment. In treatments including Naxcel, Titanium 5, and sterile water Bio-Bullet and 
traditional needle comparisons, cattle were administered the dosage intramuscularly in 
either the neck (prescapular) or round (lower quarter) region.  The Vira Shield 5 
treatment group was injected in the neck region subcutaneously.  A trained Solid Tech 
Animal Health representative administered all Bio-Bullet dosages at a distance of 6.1 
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meters, while trained Oklahoma State University Staff administered all other injections. 
Biobullet and traditional injections were placed in the same location either in the neck or 
in the round.  Administration of products followed protocol approved by the Institutional 
Animal Care and Use Committee at Oklahoma State University (IACUC # AG0666).  
Harvest and Meat Samples. After completion of the finishing period, (n = 191) steers 
were transported to Emporia, KS for harvest at a commercial abbatoir.  Cattle were 
tracked through the facility from the immobilization box to the rapid chilling cooler to 
maintain animal identity.  After harvest and chilling, trained Oklahoma State University 
personnel collected and recorded carcass data and identified the chuck or round in order 
to maintain carcass identity through fabrication.  After the completion of carcass data 
collection, rounds or chucks were tagged and inked for identity and carcasses were 
fabricated according to Institutional Meat Purchasing Specifications (IMPS; USDA, 
1996). Outside round flats (bicep femoris muscle, IMPS #171a) and 2-piece boneless 
chucks (IMPS #115 ) from the right side were collected for the trial. Subprimals were 
vacuum packaged and transported back to the Oklahoma State University Food and 
Agriculture Products Center where they were aged 14 days at 3°C ± 1°C.   
After the aging period, each subprimal (n = 129) was fabricated into 1.27 cm 
steaks on a sanitized commercial band saw.  After fabrication, each steak was observed 
and palpated for the presence of injection-site lesions by trained Oklahoma State 
University personnel.  When a lesion was identified, the lesion was verbally described 
using the 5-point classification system as described by Dexter et al. (1994), which 
categorizes lesions as cystic, scar with nodules, mineralized scar, clear scar, or woody 
callus.  If a lesion was present, steaks were identified to represent the center or core of the 
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lesion, and steaks representing areas that were 2.54, 5.08 and 7.62 away from the lesion 
core.  A steak was taken to represent the same muscle as far from the core as possible and 
additional control and lesioned steaks were also taken for proximate and hydroxyproline 
analysis.  Furthermore, if large enough, a portion of the lesion was excised for 
histological examination to verify that tissue damage was the result of an injection.  If no 
lesion was found in the subprimal, steaks were taken from the region where the lesion 
should have occurred (i.e., where the injection was given) along with a control steak for 
Warner-Bratzler Shear Force testing, proximate analysis and collagen determination.   
 
Warner-Bratzler Shear Force. Steaks were randomly assigned to cooking order across 
treatment group.  Steaks were allowed to temper for 24 h at 4°C prior to cooking and 
were then broiled on an impingement oven (model 11132-00-A; Lincoln Impinger, Fort 
Wayne, IN) at 180°C to an internal temperature of 70°C.  Internal steak temperatures 
were monitored using copper constantan thermocouples (model OM-202; Omega 
Engineering, Inc., Stamford, CT).  Steaks were allowed to cool for 2 h to 25°C before 
coring. The Warner Bratzler Shear Force (WBSF) at the lesion site and the average of the 
WBSF for the four cores at each distance of 2.54, 5.08, and 7.62 cm from the lesion 
location was calculated and recorded for each steak. Cores 1.27 cm in diameter, were 
removed parallel to the muscle fiber orientation from each steak.  Following the 
procedure outlined by George et al. (1995), a core was removed from the immediate area 
near the lesion core/product administration location, and four additional cores were 
removed at a radial distance of 2.54, 5.08, and 7.62 cm from the lesion/administration 
location.  Each core was sheared once by a Warner-Bratzler head attached to an Instron 
Universal Testing Machine (model 4502; Instron Corp., Canton, MA) at a crosshead 
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speed of 200 mm/min.   Peak force (kg) of cores as recorded by an IBM PS2 (Model 55 
SX) using software provided by the Instron Corp. (Canton, MA).     
Histological Examination. Histopathological examinations of muscle samples were 
performed by the Oklahoma Animal Disease Diagnostic Laboratory at Oklahoma State 
University to verify that tissue damage was a result of an injection.  Tissue samples were 
placed in 10% formaldehyde solution for fixation and coded for submission so that the 
product administered, or the distance of the sample from the lesion center was unknown 
to the pathologist evaluating the muscle sections.  Slides were prepared using Masson’s 
trichrome connective tissue stain (Luna, 1968). 
Proximate Analysis. Proximate analysis of the samples was performed in duplicate and 
averaged according to the procedures outlined by AOAC (1990).  Each sample was 
frozen individually in liquid nitrogen and pulverized to a powder in a Waring blender 
(Dynamics Co. of America, New Hartford, CT).  Three grams of the powdered sample 
was placed in filter paper, dried at 100°C for 24 h, desiccated for 1 h, and reweighed to 
determine moisture.  Following moisture determination, each sample was placed in a 
soxhlet for 24 h for ether extraction of lipid, followed by drying at 100°C for no more 
than 12 h.  Each sample was desiccated and re-weighed to calculate lipid content.  
Collagen Determination. Hydroxyproline is quantitatively determined as a measure of 
collagenous material in meat and meat products.  Collagenous connective tissue contains 
12.5% hydroxyproline when a collagen-protein factor of 6.25 is used (Kolar, 1990).  To 
determine the collagen content, a sample was freeze dried using liquid nitrogen and 
powdered using a blender as described above.   A 4 g sample was then hydrolyzed using 
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sulfuric acid at 105ºC for approximately 16 h.  Upon completion of heating, solution was 
filtered and diluted using protocol as listed by Kolar (1990).  The hydroxyproline was 
oxidized by using chloramine –T.  The reddish purple color that developed after the 60ºC 
water bath was a result of the addition of 4-dimethylaminobenzaldehyde.  After arriving 
at this step, the sample is measured photometrically at 560 nm.  Upon retrieving 
absorption data from spectrophotometer, the calculation of hydroxyproline content (H) 
was as follows:  H,g/100 g = (h X 2.5) / (m X V), where h = hydroxyproline, Xg/2 mL 
filtrate, read from calibration curve; m = weight of sample, g; and V = volume, mL, of 
filtrate taken for dilution to 100 mL for the hydrolysis step.  The result from this 
calculation was an arithmetic mean of two calculated values for each sample.  In 
calculating the collagenous connective tissue content (B), the following formula was 
utilized:  B,g /100 g = H X 8.  It should be noted that collagenous connective tissue 
contains 12.5% hydroxyproline if the nitrogen-to-protein factor is 6.25. 
 
Statistical Analysis. All post harvest results were analyzed using General Linear Model 
(PROC MIXED, SAS Inst., Inc., Cary, NC).  Feedlot performance (BW, DMI, ADG, 
G:F) was analyzed using the Mixed Procedure of SAS with pen as the experimental unit.  
Drug administered, injection technique, and drug x injection method were initially 
included in the model.  However, the interaction was not significant (P > 0.2) for all 
variables and it was removed from the model.  Because all steers were administered 
Naxcel and a viral vaccine, only injection technique was included in the final model. Data 
were analyzed to determine the effect of pharmaceutical, route of administration, and 
pharmaceutical by route of administration on lesion occurrence, Warner-Bratzler Shear 
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Force, and fat and collagen content. Means were separated when a significant F test (Y =
0.05) was observed.  Means were separated using a pair-wise t-test.   
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CHAPTER IV 
 
RESULTS AND DISCUSSION 
Yield and Quality Grade Data.  Quality and yield grade data were collected from 
carcasses before fabrication. There was little difference in yield grade and quality grade 
between treatment groups.  However, it was observed that the Needle* Titanium 5 group 
harvested with the lowest quality grade (Slight 65) and yield grade (2.54), while the 
treatment group with the highest quality grade was Needle*Vira Shield 5 (Small 20).  
The treatment group with the highest yield grade was BioBullet* Naxcel (2.94).    
Lesion Presence. Results of visual palpation and inspection of the 69 rounds and 60 
chucks that were evaluated identified a  visual lesion in 71.83% of all Control (H20) 
rounds, which was similar to rounds injected with Naxcel, which had a 70.83% visual 
lesion presence (Table 1).  Rounds injected with Titanium 5 had a visual lesion present in 
77.83%, which was the highest percentage of all rounds and chucks. The control chucks 
and chucks injected with Titanium 5 had a visual lesion incidence percentage of 52.60% 
and 52.36%, respectively.  The highest lesion percentage occurred in chucks injected 
with Naxcel; 56.84% of chucks had a visible lesion. 
 Although lesion occurrence was not significantly different (P > 0.10) between the 
two routes of administration, 83.33% of rounds injected with a Bio-Bullet had a visible 
lesion as compared to 63.66% of rounds injected using a needle, 56.25% of chucks 
injected with a BioBullet, and 57.08% of chucks injected with a needle. This contradicts 
findings by Morgan et al. (2004) that indicated cattle receiving a BioBullet injection at 
least 21 days prior to harvest had no (P = 0.88) detectable injection site lesion in the 
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biceps femoris.  Rounds and chucks injected with Vira Shield 5 with a needle-less route 
of administration showed no significant difference (P > 0.05) in visible lesion presence 
compared to rounds and chucks injected with H20.   
 The types of lesions found in the chucks and rounds included clear scars and 
woody calluses, as well as metallic and nodular lesions.  The majority of the lesions 
identified were clear scars (n = 108 out of 129; 83.7%) in the chuck and round.  In the 2-
piece chucks that were evaluated, there were 14 lesions that were found in the clod as 
compared to the 57 lesions that were identified in the chuck roll.  Lesions found in the 
chuck roll and clod were commonly found in seam fat between the muscles, whereas the 
lesions found in the round were generally found in lean muscle tissue. In several 
instances, clear lesions found in the eye of round were long and narrow white tracks 
going across the grain of the muscle fiber.  These results indicated variable lesion type 
and occurrence in beef sub-primals from injection route and product type.  As most cattle 
receive at least one injection in their lifetime, it is of utmost importance that those 
injections are placed in the proper location.   
Histology. Histological examination of all samples confirmed the diagnosis of injection 
site lesions as described by George et al. (1995b).  It was noted that lesions within 
sections of all eight specimens revealed variable evidence of chronic fibrosing 
inflammation involving skeletal muscle and adipose tissue.  In all steaks evaluated there 
were mature fibrous tissue and collagen fibers within adipose tissue.  George et al. 
(1995b) reported that the lesion center contains dense sheets of fibroblasts with extensive 
collagen deposition, which is gradually replaced by adipose tissue as the distance from 
the lesion increases.  Additional George et al. (1995a) reported finding dense, mature 
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connective tissue with a few trapped muscle fibers and sheets of adipose tissue, resulting 
from the intramuscular injection of commercially available biological and 
pharmacological preparations into branding- and weaning-age calves.   
Tenderness. Warner-Bratzler Shear Force values for USDA Select Infraspinatus and 
Serratus ventralis muscles located in the chuck  (aged 2 d) were 4.75 kg  and 4.68 kg, 
respectively (Savell et al., 2006).  For USDA Select Biceps femoris muscle located in the 
round, the Warner-Bratzler Shear Force Value was 5.86 kg (aged 2 d) (Savell et al., 
2006).  An interaction between route of administration and product injected was observed 
in beef chuck lesion core samples and samples from 7.62 cm away from the lesion core.  
Warner-Bratzler Shear Force values of lesion site center in chucks tended to be 
significantly different (P=0.0662) than cores from the control and 2.54 and 5.08 cm away 
from the core.   In a similar study, George et al. (1995 b) reported that WBSF values from 
cores taken from the lesion site and steaks 2.54, 5.08, and 7.62 cm from the lesion were 
significantly different (P < 0.001) from the corresponding measurements in control 
steaks.  
 Lesion cores from the BioBullet*Titanium 5 had a WBSF value of 7.01 kg, 
which were significantly different (P < 0.05) from lesion center cores from chucks 
injected with a BioBullet H20 or a Needle Naxcel where WBSF values were 6.27 kg and 
5.08 kg, respectively.  However, this contradicts research conducted by Morgan et al. 
(2004) in which only steers treated with a BioBullet injection at 7 or 14 days before 
harvest displayed the presence of injection lesions in the biceps femoris; thus, no 
detrimental effects on beef tenderness would likely be realized with BioBullet treatment 
21 days or more before slaughter.  The steak for the same interactions of BioBullet* 
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Titanium 5, BioBullet*H20, Needle*Naxcel were 4.78 kg, 4.73 kg, and 4.61 kg,  
respectively.  WBSF values for samples 7.62 cm away from the lesion center were 
significantly different in shear force values, with the toughest samples resulting from the 
needle*H20 interaction group (6.35 kg).   
Warner-Bratzler Shear Force values for chuck steaks taken at 2.54 cm and 5.08 
cm away from the lesion core were not significant, although in all instances by product or 
by route, those samples required more force to shear than those of the control chuck 
steaks. Cores from Vista 5 * Needleless injections showed no significant difference from 
control steak cores.  These data support findings by George et al., (1995) that concludes 
that when an injection is administered in beef cattle, the tenderness of affected tissues is 
significantly reduced at, and an area up to 7.62 cm away from the lesion center.  
Tenderness is a key factor in satisfaction for beef consumers. If there are injection lesions 
present, it will likely affect a large portion of the cut of meat and consequently increase 
the odds of an unpleasant eating experience and a dissatisfied customer. 
Collagen Content. Tenderness is impacted by the amount of collagen and connective 
tissue that occurs in the muscle.  When a wound or injury occurs, the healing process 
involves the deposition of connective tissue and collagen in and around that wound.  
There was no significant differences (P > 0.05) found in the total collagenous connective 
tissue in samples extracted from the chuck or round.  Although there were differences 
found in WBSF values between treatments in chucks, this does help to explain the 
similarities in WBSF values for rounds.  Total collagenous connective tissue content for 
Vista 5* needle-less steaks was significantly different (P = 0.03) from control steaks. 
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Lipid Content. Lipid concentrations also vary with tenderness and muscle damage, as 
increased amounts of fat create more tender beef in post mortem muscle. In addition, 
when damage occurs in living muscle, fat deposition increases.  The comparison between 
the lesion site and control (no lesion site) samples for lipid concentration showed no 
significant difference for route or product in the round.  However, for lipid concentrations 
in the chuck, values calculated from steaks from the Titanium 5 treatment group were 
shown to be significantly different (P < 0.05) from steaks from the Naxcel treatment 
group.  However, H20 steaks were not different from Naxcel steaks (P = 0.10) or the 
Titanium 5 vaccine steaks (P = 0.29).  This is supported by the findings of Morgan et al. 
(2004) and George et al. (1995b) that lipid content is higher at the lesion site than in the 
control steak. Lipid content findings in steaks from Vira Shield 5 * needle-less were 
significantly higher (P < 0.01) when compared to lipid content of control steaks.  
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IMPLICATIONS 
Although injection-site lesions are decreasing in prevalence, new technologies 
have given a new twist to the traditional needle and syringe.  Utilizing these new routes 
of administration may ease the stress of handling livestock several times for repeated 
vaccination, but concern must be raised in that the emerging technology causes similar 
amounts of tissue damage in valuable muscle.  From a production standpoint, the results 
indicate that it is still best to administer vaccines to cattle anterior to the scapula to 
decrease the chance of lean tissue being damage, resulting in trim loss and tenderness.  
Moreover, we can estimate losses due to extra handling of animals, trim loss, etc, but we 
cannot calculate the cost of a lost consumer due to poor beef palatability as a result of a 
injection lesion.   
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Table 1.  Lesion presence percentage in beef subprimals (n = 129)1 stratified by product type. 
 
Product Type  
Control (H20)     Naxcel 
 
Titanium 5 
 
SEM 
 
P > F2
Round 
 
71.83% 
 
70.83% 
 
77.83% 
 
3.79 
 
0.29 
Chuck 
 
52.60% 
 
65.04% 
 
52.36% 
 
7.23 
 
084 
1N = 129: n = 69 for round by product type;; n = 60 for chuck by product type 
2Probability of overall F test 
30 
 
Table 2.  Lesion presence percentage in beef subprimals (n = 129)1 stratified by product  
 
Bio-Bullet 
 
Needle 
 
SEM 
 
P > F2
Round 83.33% 
 
63.66% 
 
13.88 
 
0.29 
Chuck 
 
56.25% 
 
57.08% 
 
0.59 
 
0.84 
1N = 129: n = 69 for round by product type;  n = 60 for chuck by product type 
2Probability of overall F test 
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3.  Warner-Bratzler Shear Force values (kg) in beef rounds (n = 51)1 stratified by 
product  
 
Product Type 
Sample Location 
 
H202 Naxcel3 Titanium 44 SEM 
 
P > F5
Control6 5.12 5.17 5.27 0.07 0.53 
 Lesion Core 4.53 4.66 6.66 1.20 0.19 
 2.45 cm from Core 4.93 4.61 5.25 0.32 0.33 
5.08 cm from Core 5.06 4.68 5.78 0.56 0.23 
7.62 cm from Core 4.54 5.05 4.86 0.25 0.61 
1N = 51: n = 16 for  H20; n = 17 for Naxcel; n = 18 for MLV vaccine 
2Represents rounds injected with control (saline) solution. 
3Represents rounds injected with Naxcel, a ceftiofur sodium product 
4Represents rounds injected with a Titanium 5, a modified live vaccine for IBR, BVD, 
BRSV, and PI3
5Probability of F Test 
6 Sample from same muscle in same round or chuck with lesion, but excised on 
opposite end of muscle from lesion 
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Table 4.  Warner-Bratzler Shear Force values (kg) in beef rounds (n = 51)1 stratified by 
route of administration 
 
Route of Administration 
Sample Location 
 
Bio-Bullet 
 
Needle 
 
SEM 
 
P > F2
Control3 5.36 5.02 0.24 0.53 
Lesion Core 5.16 5.41 0.17 0.19 
 2.45 cm from Core 4.69 5.17 0.33 0.33 
5.08 cm from Core 4.88 5.47 0.41 0.23 
7.62 cm from Core 4.73 4.90 0.11 0.61 
1N = 51: n = 30 for Bio-Bullet; n = 21 for Needle. 
2Probability of F Test 
3Sample from same muscle in same round or chuck with lesion, but excised on opposite end 
of muscle from lesion 
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Table 5.  Warner-Bratzler Shear Force valued (kg) in beef chuck lesion site cores stratified by 
product * route interaction. 
 
Route * Product 
 
Control1 Lesion Center 
Bio-Bullet * Titanium 52 4.78 
 
7.01a
Bio-Bullet * H203 4.73 
 
6.27ab 
Needle * Naxcel4 4.61 
 
5.08abc 
Needle * Titanium 52 4.44 
 
4.66bc 
Needle * H203 4.29 
 
4.61bc 
Bio-Bullet * Naxcel4 4.83 
 
3.81c
SEM 
 
0.31 
 
0.15 
P > F5 0.93 
 
0.06 
a,b,c Within a column, means without a common superscript letter differ (P < 0.05) 
1Sample from same muscle in same round or chuck with lesion, but excised on opposite end 
of muscle from lesion 
2Represents rounds injected with Titanium 5, a modified live vaccine for IBR, BVD, BRSV, 
and PI3
3Represents rounds injected with control (saline) solution. 
4Represents rounds injected with Naxcel, a ceftiofur sodium product 
5Probability of  F Test 
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Table 6. Warner-Bratzler Shear Force values (kg) in beef chuck lesion site cores (n = 34)1
extracted 2.54 cm  and 5.08 cm from lesion center in relation to product  
 
Product Type 
Sample Location H202 Naxcel3 Titanium 54 SEM P > F5
Control6 4.65 4.50 4.56 0.07 0.92 
 2.54 cm from Core 5.28 4.61 4.81 0.33 0.62 
5.08 cm from Core 5.16 4.75 4.89 0.20 0.90 
1N = 34: n = 10 for Control Product; n = 13 for Ceftiofur Sodium; n = 11 for MLV vaccine 
2Represents rounds injected with control (saline) solution. 
3Represents rounds injected with Naxcel, a ceftiofur sodium product 
4Represents rounds injected with a Titanium 5, a modified live vaccine for IBR, BVD, BRSV, 
and PI3
5Probability of F Test 
6Sample from same muscle in same round or chuck with lesion, but excised on opposite end 
of muscle from lesion 
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Table 7. Warner-Bratzler Shear Force values (kg) in beef chuck lesion site cores (n = 34)1
extracted 2.54 cm  and 5.08 cm from lesion center in relation to route of administration 
 
Route of Administration 
Bio-Bullet Needle SEM P > F2
Control3 4.67 4.48 0.12 0.92 
 2.54 cm from Core  4.91 4.89 0.01 0.62 
5.08 cm from Core  4.87 5.00 0.09 0.90 
1N = 34: n = 17 for Bio-Bullet; n = 17 for Needle. 
2Probability of F Test 
3Sample from same muscle in same round or chuck with lesion, but excised on opposite 
end of muscle from lesion 
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Table 8. Warner-Bratzler Shear Force values (kg) in beef chuck lesion site cores extracted 
7.62 cm from lesion center with interaction to product and route 
 
Route * Product 
 
Control1 7.62 cm from lesion core 
Needle * H202 4.78 6.35ab 
Bio-Bullet * H202 4.73 4.84b
Needle * Naxcel3 4.61 4.77b
Bio-Bullet * Naxcel3 4.44 4.28b
Needle * Titanium 54 4.29 4.27b
Bio-Bullet* Titanium 54 4.83 3.67b
SEM 0.31 0.33 
P> F5 0.93 0.02
a,b,c Within a column, means without a common superscript letter differ (P < 0.05) 
1Sample from same muscle in same round or chuck with lesion, but excised on opposite end 
of muscle from lesion 
2Represents rounds injected with control (saline) solution. 
3Represents rounds injected with Naxcel, a ceftiofur sodium product 
4Represents rounds injected with Titanium 5, a modified live vaccine for IBR, BVD, BRSV, 
and PI3
5Probability of  F Test 
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Table 9.  Collagenous connective tissue content (mg/g) (n = 64)1 of lesion stratified by product 
type  
 
Product Type 
H202 Naxcel3 Titanium54 SEM 
 
P > F5
Round 
 
Control6 0.71 0.75 0.85 0.07 0.23 
 Lesion 2.04 0.78 0.76 0.73 0.42 
Chuck      
 Control6 2.02 0.90 1.06 0.59 0.39 
Lesion 1.20 1.79 1.30 0.30 0.20 
1N = 64: n = 41 for Round by Product; n =  23 for Chuck by Product 
2Represents rounds injected with control (saline) solution. 
3Represents rounds injected with Naxcel, a ceftiofur sodium product 
4Represents rounds injected with a Titanium 5, a modified live vaccine for IBR, BVD, BRSV, 
and PI3
5Probability of F Test 
6Sample from same muscle in same round or chuck with lesion, but excised on opposite end of 
muscle from lesion 
 
38 
 
Table 10.  Collagenous connective tissue content (mg/g) (n = 64)1 of lesion stratified 
by route of administration. 
 
Bio-Bullet® Needle SEM P > F2
Round     
Control3 0.74 0.80 0.45 0.23 
Lesion. 1.62 0.76 0.58 0.42 
Chuck     
Control3 0.98 1.67 0.48 0.39 
Lesion 1.58 1.28 0.19 0.20 
1N = 64: n = 41 for Round by Route; n = 23 for Chuck by Route. 
2Probability of F Test 
3Sample from same muscle in same round or chuck with lesion, but excised on opposite 
end of muscle from lesion 
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Table 11.  Lipid concentration percentage (n = 69)1 of lesion stratified by product type  
 
Product Type 
H202 Naxcel3 Titanium 54 SEM P > F5
Round      
Control6 4.69 5.52 5.04 0.44 0.35 
 Lesion  3.70 3.83 3.33 0.25 0.85 
Chuck      
Control6 6.34ab 8.22a 5.14bc 1.57 0.02 
Lesion  6.45 8.05 4.01 1.94 0.25 
a,b,c Within a column, means without a common superscript letter differ (P < 0.05) 
1N = 69: n = 45 for Round by Product; n = 24 for Chuck by Product 
2Represents rounds injected with control (saline) solution. 
3Represents rounds injected with Titanium 5, a modified live vaccine for IBR, BVD, BRSV, 
and PI3
4Represents rounds injected with Naxcel, a ceftiofur sodium product 
5Probability of  F Test 
6Sample from same muscle in same round or chuck with lesion, but excised on opposite end 
of muscle from lesion 
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Table 12.  Lipid concentration percentage (n = 69)1 of lesion stratified by route of 
administration. 
 Route of Administration 
Bio-Bullet Needle SEM P > F2
Round     
Control3 4.93 5.23 0.17 0.35 
Lesion  3.42 3.82 0.27 0.85 
Chuck     
Control3 7.22 5.91 0.93 0.02 
Lesion  7.08 5.26 1.21 0.25 
a,b,c Within a column, means without a common superscript letter differ (P < 0.05) 
1N = 69: n = 45 for Round by Route, n = 24 for Chuck by Route 
*Probability of  F Test 
3Sample from same muscle in same round or chuck with lesion, but excised on 
opposite end of muscle from lesion 
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